Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Inventory for 4 consecutive years, with $310000.0 as the latest value for Q4 2025.

  • Quarterly Inventory rose 79.19% to $310000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $310000.0 through Dec 2025, up 79.19% year-over-year, with the annual reading at $310000.0 for FY2025, 79.19% up from the prior year.
  • Inventory for Q4 2025 was $310000.0 at Orchestra BioMed Holdings, down from $365000.0 in the prior quarter.
  • The five-year high for Inventory was $365000.0 in Q3 2025, with the low at $70000.0 in Q2 2024.
  • Average Inventory over 4 years is $196615.4, with a median of $178000.0 recorded in 2023.
  • The sharpest move saw Inventory plummeted 60.67% in 2024, then surged 164.29% in 2025.
  • Over 4 years, Inventory stood at $276000.0 in 2022, then tumbled by 47.1% to $146000.0 in 2023, then increased by 18.49% to $173000.0 in 2024, then skyrocketed by 79.19% to $310000.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $310000.0, $365000.0, and $185000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.